PLA2G4B anticorps (N-Term)

N° du produit ABIN927721

Détail du produit anti-PLA2G4B anticorps

Antigène: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Épitope: N-Term

Reactivité: Humain, Souris, Rat, Boeuf (Vache)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLA2G4B est non-conjugé

Application: Western Blotting (WB)

Réactivité croisée: Souris, Rat (Rattus), Boeuf (Vache)

Purification: Purified

Immunogène: PLA2 G2 antibody was raised in rabbit using the N terminal of PLA2 2 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

PLA2G4B Blocking Peptide, catalog no. 33R-1112, is also available for use as a blocking control in assays to test for specificity of this PLA2G4B antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur PLA2G4B

Antigène: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Autre désignation: PLA2G4B (PLA2G4B Produits)

Synonymes: anticorps HsT16992, anticorps cPLA2-beta, anticorps A030011C02Rik, anticorps Gm1013, anticorps phospholipase A2 group IVB, anticorps phospholipase A2, group IVB (cytosolic), anticorps PLA2G4B, anticorps Pla2g4b

Sujet: PLA2G4B gene transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Synonyms: Polyclonal PLA2G4B antibody, Anti-PLA2G4B antibody, phospholipase A2, group IVB, cytosolic antibody, FLJ42498 antibody, HsT16992 antibody, cPLA2-beta antibody.

Pathways: ER-Nucleus Signaling, VEGF Signaling